|
|
|
|
α1D-adrenoceptor
|
|
|
Hs |
Agonist |
Full agonist |
5.5 – 7.4 |
pKi |
- |
13,21,23 |
|
| ⤷ |
pKi
5.5 – 7.4
[13,21,23]
|
|
α1D-adrenoceptor
|
|
|
Rn |
Agonist |
Full agonist |
6.3 |
pKi |
- |
17 |
|
| ⤷ |
pKi
6.3
[17]
|
|
α2C-adrenoceptor
|
|
|
Hs |
Agonist |
Full agonist |
4.5 – 6.8 |
pKi |
- |
15-16,18,20 |
|
| ⤷ |
pKi
4.5 – 6.8
[15-16,18,20]
|
|
α1A-adrenoceptor
|
|
|
Hs |
Agonist |
Full agonist |
4.8 – 6.4 |
pKi |
- |
7,10,13,21-23,25 |
|
| ⤷ |
pKi
4.8 – 6.4
[7,10,13,21-23,25]
|
|
α2A-adrenoceptor
|
|
|
Hs |
Agonist |
Full agonist |
3.6 – 7.4 |
pKi |
- |
15,18,20 |
|
| ⤷ |
pKi
3.6 – 7.4
[15,18,20]
|
|
β3-adrenoceptor
|
|
|
Hs |
Agonist |
Agonist |
4.4 – 6.3 |
pKi |
- |
4,6,12,19,24,26 |
|
| ⤷ |
pKi
4.4 – 6.3
[4,6,12,19,24,26]
|
|
β1-adrenoceptor
|
|
|
Hs |
Agonist |
Agonist |
4.6 – 6.0 |
pKi |
- |
4-5,11-12,24 |
|
| ⤷ |
pKi
4.6 – 6.0
[4-5,11-12,24]
|
|
α1B-adrenoceptor
|
|
|
Hs |
Agonist |
Full agonist |
3.8 – 6.2 |
pKi |
- |
21,23 |
|
| ⤷ |
pKi
3.8 – 6.2
[21,23]
|
|
β2-adrenoceptor
|
|
|
Hs |
Agonist |
Agonist |
4.6 – 5.4 |
pKi |
- |
4,11-12,14,24 |
|
| ⤷ |
pKi
4.6 – 5.4
[4,11-12,14,24]
|
|
α2B-adrenoceptor
|
|
|
Hs |
Agonist |
Full agonist |
3.5 – 6.0 |
pKi |
- |
15,18,20 |
|
| ⤷ |
pKi
3.5 – 6.0
[15,18,20]
|
|
β3-adrenoceptor
|
|
|
Mm |
Agonist |
Full agonist |
3.8 – 5.7 |
pKi |
- |
6,19,24 |
|
| ⤷ |
pKi
3.8 – 5.7
[6,19,24]
|
|
β3-adrenoceptor
|
|
|
Rn |
Agonist |
Agonist |
4.2 |
pKi |
- |
19 |
|
| ⤷ |
pKi
4.2
[19]
|
|
α1B-adrenoceptor
|
|
|
Hs |
Agonist |
Full agonist |
9.2 |
pEC50 |
- |
21 |
|
| ⤷ |
pEC50
9.2
[21]
|
|
α1A-adrenoceptor
|
|
|
Hs |
Agonist |
Full agonist |
7.7 – 8.6 |
pEC50 |
- |
7,10,21 |
|
| ⤷ |
pEC50
7.7 – 8.6
[7,10,21]
|
|
β3-adrenoceptor
|
|
|
Mm |
Agonist |
Agonist |
7.9 |
pEC50 |
- |
6 |
|
| ⤷ |
pEC50
7.9
[6]
|
|
α1D-adrenoceptor
|
|
|
Hs |
Agonist |
Full agonist |
7.8 |
pEC50 |
- |
21 |
|
| ⤷ |
pEC50
7.8
[21]
|
|
β1-adrenoceptor
|
|
|
Mg |
Agonist |
Agonist |
7.7 |
pEC50 |
- |
3 |
|
| ⤷ |
pEC50
7.7
[3]
|
|
β3-adrenoceptor
|
|
|
Hs |
Agonist |
Agonist |
7.2 – 8.2 |
pEC50 |
- |
1,4,6 |
|
| ⤷ |
pEC50
7.2 – 8.2
[1,4,6]
|
|
β1-adrenoceptor
|
|
|
Hs |
Agonist |
Agonist |
7.1 – 7.9 |
pEC50 |
- |
2,4-5 |
|
| ⤷ |
pEC50
7.1 – 7.9
[2,4-5]
|
|
β2-adrenoceptor
|
|
|
Hs |
Agonist |
Agonist |
5.4 – 6.4 |
pEC50 |
- |
4,8 |
|
| ⤷ |
pEC50
5.4 – 6.4
[4,8]
|
|
α2B-adrenoceptor
|
|
|
Hs |
Agonist |
Full agonist |
7.8 |
pIC50 |
- |
20 |
|
| ⤷ |
pIC50
7.8
[20]
Description: inhibition of forskolin stimulated cAMP generation
|
|
α2C-adrenoceptor
|
|
|
Hs |
Agonist |
Full agonist |
6.5 – 8.6 |
pIC50 |
- |
16,20 |
|
| ⤷ |
pIC50
6.5 – 8.6
[16,20]
Description: inhibition of cAMP production
|
|
α2A-adrenoceptor
|
|
|
Hs |
Agonist |
Full agonist |
6.6 |
pIC50 |
- |
20 |
|
| ⤷ |
pIC50
6.6
[20]
Description: inhibition of forskolin stimulated cAMP generation
|
|